-+ 0.00%
-+ 0.00%
-+ 0.00%

BMO Capital Maintains Outperform on Eli Lilly, Raises Price Target to $1200

Benzinga·12/04/2025 14:00:32
语音播报
BMO Capital analyst Evan Seigerman maintains Eli Lilly (NYSE:LLY) with a Outperform and raises the price target from $1100 to $1200.